North America Psychedelic Drugs Market Trends, Insights and Forecast 2021 – 2027 | Key Players – NeuroRX, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals

A latest survey on North America Psychedelic Drugs Market report puts a light on primary and secondary drivers, market share, leading segments, possible sales volume, and geographical analysis. This market research report contains thorough analysis of the market structure along with forecast of the various segments and sub-segments of the North America Psychedelic Drugs market. In this report, researchers look at historical records, current statistics, and future projections in detail. It offers detailed research and analysis of key aspects of the North America Psychedelic Drugs market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the market. It comprises of fundamental and advanced information related to the status and trend, market size, sales volume, market share, growth, future trends analysis, segment and forecasts from 2020 – 2027. The chief areas covered in the large scale North America Psychedelic Drugs report include market definition, market segmentation, competitive analysis and research methodology.

Psychedelic Drugs Market

North America psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 15.8% in the forecast period of 2020 to 2027 and expected to reach USD 6,846.68 million by 2027. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth.

Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @

The Major players reported in the market include:

  • Johnson & Johnson Services, Inc
  • Jazz Pharmaceuticals, Inc
  • Celon Pharma SA
  • Develco pharma schweiz ag
  • Doughlas pharmaceuticals limited
  • NeuroRX, Inc
  • Hikma Pharmaceuticals PLC
  • Amneal Pharmaceuticals, LLC              

North America Psychedelic Drugs Market Segmentation:

By Source (Synthetic, Natural), Type (Dissociatives, Empathogens, Serotonergic (Classical Psychedelic Drugs)

By Application (Narcolepsy, Treatment-Resistant Depression, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder, Others), Route of Administration (Oral, Intranasal, Parenteral, Others), Drugs (Gamma Hydroxybutyric Acid (GHB), Ketamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), Psilocybin)

By End User (Hospitals, Speciality Clinic, Research Organization, Others)

By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy, Others)

The North America Psychedelic Drugs report covers all the market shares and approaches of the major competitors or the key market players. Such highlights about competitive landscape plays very important role in deciding about the enhancements required in the product already in the market or the future product. The report also performs systemic analysis of growth trends and future prospects. Besides, this market report contains an extensive evaluation of the market growth prospects and restrictions. An influential North America Psychedelic Drugs market report offers an utter background analysis of the North America Psychedelic Drugs industry along with an assessment of the market. The market analysts and researchers have done extensive analysis of the North America Psychedelic Drugs market with the help of research methodologies such as PESTLE and Porter’s Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario.

Table Of Content: North America Psychedelic Drugs Market:

Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation Overview

Chapter 2: Market Competition by Manufacturers

Chapter 3: Production by Regions

Chapter 4: Consumption by Regions

Chapter 5: Production, By Types, Revenue and Market share by Types

Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications

Chapter 7: Complete profiling and analysis of Manufacturers

Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise Manufacturing expenses

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Effect Factors Analysis

Chapter 12: North America Psychedelic DrugsMarket Forecast

Chapter 13: Research Findings and Conclusion, Appendix, methodology and data source


Browse North America Psychedelic Drugs Market Research Report with detailed TOC at:

The latest report is the latest study to offer 360 ° coverage of the North America Psychedelic Drugs industry, which has been hit by the negative economic impact of the COVID-19 outbreak since the beginning of this year.

Competitive Landscape and North America Psychedelic Drugs Market Share Analysis

The major players covered in the report are Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma SA, COMPASS,, Develco pharma schweiz ag, Doughlas pharmaceuticals limited, NeuroRX, Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, LLC., AVADEL PHARMACEUTICALS, PLC among other players in North America DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

In January 2020, COMPASS received the U.S Patent for COMP 360, a formulation of psilocybin. Helps the patenting company to develop a developmental condition for treating depression. This is a novel product because the patent increases their revenue.

In January 2019, Douglas Pharmaceuticals Ltd launched a clinical trial for phase 2 of ketamine for the treatment of depression – for patients with depression. Helping the company launch a new product in the clinical trial market.

North America Psychedelic Drugs Market Scope and Market Size

  • On the basis of source, the market is segmented into synthetic and natural.
  • On the basis of type, the market is segmented into dissociatives, empathogens, and serotonergic (classical psychedelic drugs).
  • On the basis of application, the market is segmented into narcolepsy, treatment-resistant depression, post-traumatic stress disorder (PTSD), major depressive disorder, others.
  • On the basis of route of administration, the market is segmented into oral, intranasal, parenteral, others.
  • On the basis of drugs, the market is segmented into gamma hydroxybutyric acid (GHB), ketamine, 3, 4-methylenedioxymethamphetamine (ecstasy), psilocybin.
  • On the basis of end user, the market is segmented into hospitals, speciality clinic, research organisation, others.
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, compounding pharmacy, others.

The key countries in each region are taken into consideration as well, such as United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire Here Get customization & Get discount for report:

This North America Psychedelic Drugs Market Research Report Contains Answers to your following Questions:

Which Manufacturing Technology is Used for North America Psychedelic Drugs? What Growth Potential Are Going On in That Technology? Which Trends Are Causing These Developments?

Who Are the Key Players in This North America Psychedelic Drugs Market? What’s Their Company Profile, Their Product Information, and Contact Information? Which product segment will get the most?

What Was Market Strategies of North America Psychedelic Drugs Market? What Was Capacity, Production Value, Cost and PROFIT of North America Psychedelic Drugs Market?

What Is Current Market Status of North America Psychedelic Drugs Industry? What’s Market Competition in This Industry, Both Company, and Country Wise? What’s Market Analysis of Market by Taking Applications and Types in Consideration?

What Are The Growth Opportunities That May Arise In The Industry in the Coming Years?

What Is North America Psychedelic Drugs Market Chain Analysis by Upstream Raw Materials and Downstream Industry?

What Is Economic Impact On North America Psychedelic Drugs Industry? What are Macroeconomic Environment Analysis Results? What Are Macroeconomic Environment Development Trends?

What Are Market Dynamics of Market? What are the key trends that positively impact market growth?

What Should Be Entry Strategies, Countermeasures to Economic Impact, Marketing Channels for Industry?

Thank you for reading our report. Customization of the report is available as per client requirements.  Kindly get in touch with us to know more about the report.

About Data Bridge Market Research Private Ltd:

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Related Articles

Back to top button